leisure time -WSS

leisure time

author：hotspot 2025-10-02 22:30:10 - browse：1

Illustration of a person holding a phone with apps and small people (patients and doctors) on the screen. -- chronic disease coverage from STAT — Molly Ferguson for STAT

If her neurologist moved to China, Lauren Stiles says she’d follow him there. “There’s so few doctors who do this,” said the New York-based president of patient advocacy group Dysautonomia International.

In her world, informed, experienced specialists — particularly in the autonomic nervous system — are extremely rare. Telehealth can open doors for patients who have been searching for a doctor who understands them. Stiles had to travel hundreds of miles to find an expert at the Cleveland Clinic who could diagnose her (it took two years to figure out she has postural orthostatic tachycardia syndrome, or POTS, and Sjögren’s syndrome). When that last-ditch doctor moved to Virginia, she followed him.

But many times, Stiles has questions that shouldn’t take a dozen-hour road trip to answer. She’d love to call him up and have an appointment over the phone.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： Ukraine and a new approach to mental health in war

focus

WSS

Experts study whether long Covid risk adds up with each reinfection

Drug for rare kidney disease narrowly misses mark in clinical trial

A ‘polypill’ could sharply reduce cardiovascular disease in the U.S.

Drug for rare kidney disease narrowly misses mark in clinical trial

Ukraine and a new approach to mental health in war

Vaccine advisory panel ACIP left half staffed by HHS

entertainment

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

knowledge

Anesthesiologist group: stop taking Ozempic before surgery

What we’ve learned from the Aduhelm mess

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Case for ALS therapy Nurown relies on ‘deficient’ data, FDA finds

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Readout Newsletter: Biogen, Rocket Pharma, KalVista, and more

Medical leaders decry Supreme Court decision on affirmative action

Drug for rare kidney disease narrowly misses mark in clinical trial

BioMarin wins approval for gene therapy to treat hemophilia A

CDC advisers recommend seasonal use of Pfizer RSV shot

Wikipedia

Experts study whether long Covid risk adds up with each reinfection

How AI helped researchers track recovery from depression

For Medicare Advantage, Democrats want stronger protections around AI

Thermo Fisher plant for manufacturing gene therapies to expand

How Vertex's cystic fibrosis drug is changing patients' lives

What we’ve learned from the Aduhelm mess

focus

explore

knowledge

hotspot